Inventor

Jennifer Riggs-Sauthier

Inventor

San Francisco, CA, US

Overview

2002–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 93 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes33%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%

C07DHeterocyclic compounds18%

C07CAcyclic or carbocyclic compounds9%

C07HSugars2%

C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%

C08LCompositions of macromolecular compounds2%

Y02ATechnologies for adaptation to climate change2%

C07BGeneral methods of organic chemistry1%

C07JSteroids0%

PatentTitleYear

10,869,933Oligomer-phenothiazine conjugates2020 10,844,076Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine2020 10,736,969Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds2020 10,512,644Oligomer-opioid agonist conjugates2019 10,485,877Oligomer-phenothiazine conjugates2019 10,463,744Polymer-semaxanib moiety conjugates2019 10,434,181Oligomer-containing benzamide-based compounds2019 10,307,416Oligomer-opioid agonist conjugates2019 10,265,411N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides2019 10,251,959Oligomer-beta blocker conjugates2019 10,189,859Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine2019 10,143,690Oligomer-opioid agonist conjugates2018 10,039,737Multi-arm polymeric alkanoate conjugates2018 9,943,605Polymer-semaxanib moiety conjugates2018 9,937,266Oligomer-containing benzamide-based compounds2018 9,907,855'N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides'2018 9,827,239Oligomer-opioid agonist conjugates2017 9,782,488'Oligomer-beta blocker conjugates'2017 9,725,431'Oligomer-tricyclic conjugates'2017 9,616,136'N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides'2017 9,617,228'Oligomer-containing substituted aromatic triazine compounds'2017 9,540,330'Oligomer-containing hydantoin compounds'2017 9,512,135'Oligomer-opioid agonist conjugates'2016 9,504,755'Multi-arm polymeric alkanoate conjugates'2016 9,487,473'Oligomer-amino acid conjugates'2016 9,458,166'Oligomer-opioid agonist conjugates'2016 9,421,275'Oligomer-calcimimetic conjugates and related compunds'2016 9,421,204'Oligomer modified diaromatic substituted compounds'2016 9,399,033'Oligomer-containing pyrrolidine compounds'2016 9,375,486'Oligomer-containing benzamide-based compounds'2016 9,365,604'Oligomer-nucleoside phosphate conjugates'2016 9,314,463'Oligomer-diarylpiperazine conjugates'2016 9,266,845'Oligomer-containing substituted aromatic triazine compounds'2016 9,233,169'Oligomer-bis-chromonyl compound conjugates'2016 9,233,932'Oligomer-nitroimidazole anti-infective conjugates'2016 9,233,167'Oligomer-opioid agonist conjugates'2016 9,233,165'Oligomer-aryloxy-substituted propanamine conjugates'2016 9,233,168'Oligomer-opioid agonist conjugates'2016 9,226,970'Oligomer modified diaromatic substituted compounds'2016 9,226,971'N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides'2016 9,220,790'Multi-arm polymeric alkanoate conjugates'2015 9,192,681'Oligomer-amino acid conjugates'2015 9,168,311'Oligomer-dantrolene conjugates and related compounds'2015 9,155,797'Oligomer-cannabinoid conjugates'2015 9,149,538'Oligomer conjugates of heteropentacyclic nucleosides'2015 9,132,200'Oligomer-calcium channel blocker conjugates'2015 9,126,926'Oligomer-anticholinergic agent conjugates'2015 9,107,956'Oligomer-protease inhibitor conjugates'2015 9,095,622'Oligomer-protein tyrosine kinase inhibitor conjugates'2015 9,096,517'Oligomer-containing pyrrolidine compounds'2015 9,095,621'Oligome-bis-chromonyl compound conjugates'2015 9,090,535'Hydroxylated tricyclic compounds'2015 9,084,828'Oligomer-protein tyrosine kinase inhibitor conjugates'2015 9,061,026'Oligomer-diarylpiperazine conjugates'2015 8,962,566'Multi-arm polymeric alkanoate conjugates'2015 8,952,032'Oligomer-opioid agonist conjugates'2015 8,946,285'Oligomer-opioid agonist conjugates'2015 8,921,371'Oligomer-protein tyrosine kinase inhibitor conjugates'2014 8,895,553'Oligomer-containing substituted aromatic triazine compounds'2014 8,853,247'Oligomer-nitroimidazole anti-infective conjugates'2014 8,829,043'Oligome-cannabinoid conjugates'2014 8,816,077'Oligomer-protein tyrosine kinase inhibitor conjugates'2014 8,796,248'Oligomer-corticosteroid conjugates'2014 8,785,661'Oligome-containing pyrrolidine compounds'2014 8,778,898'Oligomer conjugates of heteropentacyclic nucleosides'2014 8,772,479'Oligomer-containing substituted aromatic triazine compounds'2014 8,754,197'Synthesis of azo bonded immunoregulatory compounds'2014 8,748,648'Oligomer-calcium channel blocker conjugates'2014 8,741,858'Oligomer-nucleoside phosphate conjugates'2014 8,722,732'Oligomer-calcimimetic conjugates and related compounds'2014 8,685,979'Oligomer-diarylpiperazine conjugates'2014 8,637,466'Multi-arm polymeric alkanoate conjugates'2014 8,598,364'Oligomer-protease inhibitor conjugates'2013 8,575,196'Oligomer-opioid agonist conjugates'2013 8,569,380'Oligomer-tricyclic conjugates'2013 8,569,343'Oligomer-opioid agonist conjugates'2013 8,536,213'Oligomer-dantrolene conjugates and related compounds'2013 8,530,492'Oligomer-protein tyrosine kinase inhibitor conjugates'2013 8,466,276'Oligomer conjugates of heteropentacyclic nucleosides'2013 8,440,687'Oligomer-opioid agonist conjugates'2013 8,389,759'Oligomer-anticholinergic agent conjugates'2013 8,329,958'Combinatorial synthesis of PEG oligomer libraries'2012 8,314,214'Synthesis of azo bonded immunoregulatory compounds'2012 8,173,666'Oligomer-opioid agonist conjugates'2012 7,932,366'Synthesis of azo bonded immunoregulatory compounds'2011 7,425,578'Immunoregulatory compounds and derivatives and methods of treating diseases therewith'2008 7,151,095'Immunoregulatory compounds and derivatives and methods of treating diseases therewith'2006 7,119,119'Immunoregulatory compounds and derivatives and methods of treating diseases therewith'2006 6,903,082'Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof'2005 6,730,701'6-methoxy-2-naphthylacetic acid prodrugs'2004 6,583,128'Immunoregulatory compounds and derivatives and methods of treating diseases therewith'2003 6,552,078'6-methoxy-2-naphthylacetic acid prodrugs'2003 6,458,776'5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2012Based in Raleigh, NC, US· patent location history

2006–2014Patents assigned to BIOCON LTD (6)· patent assignee history

2008–2020Based in Huntsville, AL, US· patent location history

2012–2020Patents assigned to NEKTAR THERAPEUTICS (80)· patent assignee history

2012–2020Patents assigned to RIGGS-SAUTHIER JENNIFER (30)· patent assignee history

2012–2016Patents assigned to DENG BO-LIANG (11)· patent assignee history

2013–2016Patents assigned to ZHANG WEN (8)· patent assignee history

2013–2019Based in San Francisco, CA, US· patent location history

2014Based in Hunstville, AL, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
NEKTAR THERAPEUTICS	80	2012–2020
RIGGS-SAUTHIER JENNIFERself	30	2012–2020
DENG BO-LIANG	11	2012–2016
ZHANG WEN	8	2013–2016
BIOCON LTD	6	2006–2014

Locations

Location	Patents	Span
San Francisco, California, US	46	2013–2019
Huntsville, AL, US	38	2008–2020
Raleigh, NC, US	8	2002–2012
Hunstville, AL, US	1	2014